Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Home
Browse by Poster Presenter
Browse by Poster Presenter
Type here to filter the list
All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
C
Cahayag, Rhea
Ultragenyx Pharmaceuticals
(
W1430-02-10
)
Analysis of Anti-Drug Antibodies (ADA) in Multiple Animal Species from mRNA LNP Therapeutics Supporting Rare Diseases Demonstrated Low Immunogenicity of PEG-2000 by ECLA and ELISA Methodology
Rhea Cahayag
Favorite
Calderon, Chris
Ursa Analytics
(
T1330-01-03
)
Stain-Free Approach to Determine and Monitor Cell Heath Using Supervised and Unsupervised Image-Based Deep Learning
Chris Calderon
Favorite
(
W1030-02-11
)
Machine Learning Approaches to Analysis of Microscopy Images of Polysorbate Degradation Product Particles
Chris Calderon
Favorite
Celik, Selvi
Svar Life Science AB
(
W1130-02-11
)
Comparison of a Microfluidic Generic Total Antibody (TAb) Assay with Independent Neutralizing Antibody (NAb) and TAb Assays for the Detection of Pre-existing Antibodies against AAV Vectors
Selvi Celik
Favorite
Centola, Garrick
US Food and Drug Administration
(
W1030-02-07
)
Comparative Analyses of Thermal Stability Amplifying Peptide Dendrons and Polysorbates
Garrick Centola
Favorite
Chakrapeesirisuk, Nopdanai
Uppsala University
(
W1030-02-08
)
Optimization of Artificial Colonic Mucus for Drug Diffusion Study
Nopdanai Chakrapeesirisuk
Favorite
Chang, Su-youne
Mayo Clinic
(
W1430-01-04
)
Innovative Device for Concomitant Therapeutic Compound Delivery into the Brain and Neural Recordings - Feasibility Bench and In Vivo Studies
Su-youne Chang
Favorite
Chang, Ying-Chih
Acrocyte
(
W1430-02-08
)
In Vitro Method Using Circulating Tumor Cells-Derived Organoids from Patients with Solid Tumors to Transform Oncology Drug Development
Ying-Chih Chang
Favorite
Chan, Phyllis
Genentech, Inc.
(
T1230-02-09
)
Population Pharmacokinetics and Exposure-Efficacy and -Safety Analyses of Atezolizumab for Subcutaneous Injection in Patients with Locally Advanced or Metastatic Non-small Cell Lung Cancer
Phyllis Chan
Favorite
(
T1430-02-09
)
Bridging Bevacizumab PK from Adults to Pediatrics through PBPK Modeling
Phyllis Chan
Favorite
Chanu, Pascal
Genentech, Inc.
(
T1230-02-09
)
Population Pharmacokinetics and Exposure-Efficacy and -Safety Analyses of Atezolizumab for Subcutaneous Injection in Patients with Locally Advanced or Metastatic Non-small Cell Lung Cancer
Pascal Chanu
Favorite
Chappell, John
Gyros Protein Technologies
(
T1330-02-11
)
Oligonucleotide Dual Hybridization Assay Using Offline Pre-incubation followed by an Automated Microfluidic Method
John Chappell
Favorite
(
T1530-02-10
)
Development of a Generic, Automated, Microfluidic Human IgG-FcRn Affinity Assay In-Solution for Use in Antibody Engineering
John Chappell
Favorite
Chavez, Alfonso
NeuroOne
(
W1430-01-04
)
Innovative Device for Concomitant Therapeutic Compound Delivery into the Brain and Neural Recordings - Feasibility Bench and In Vivo Studies
Alfonso Chavez
Favorite
Chengalvala, Murty
LabCorp
(
W1230-01-05
)
Development of a Marburg Self-amplifying mRNA-Lipid Nanoparticle Vaccine: Differential Effects When Co-formulated with Toll Receptor Agonists
Murty Chengalvala
Favorite
Chen, Hsin
Janssen Research & Development, LLC
(
T1130-02-09
)
Evaluation of Sample Preparation Techniques for Protein Quantification
Hsin Chen
Favorite
Chen, Ming-Luan
Altasciences
(
T1230-02-11
)
Sensitive Quantitation of Antisense Oligonucleotides Using Capitainer
®
qDBS Microsampling Device Coupled with Hybridization LC-MS/MS
Ming-Luan Chen
Favorite
Chen, Weixuan
Janssen Research & Development, LLC
(
T1130-02-09
)
Evaluation of Sample Preparation Techniques for Protein Quantification
Weixuan Chen
Favorite
Chen, Zhongying
Astrazeneca
(
W1130-02-07
)
Biodistribution Study of a Bivalent SARS-CoV-2 mRNA Vaccine in Rat
Zhongying Chen
Favorite
Chiu, Tim
Ultragenyx Pharmaceuticals
(
W1530-02-06
)
Age-Dependent Reduction in Hepatic Vector Genome Loss in Juvenile OTC
spf-ash
Mice Following a Single Dose of DTX301 and Partial Compensation Achieved with a Higher Dose
Tim Chiu
Favorite
Cho, Nick
Genentech, Inc.
(
T1030-02-09
)
Evaluating the Effects of Differently Charged Linker-Drugs on Pharmacokinetics and Tissue Distribution of Antibody Drug Conjugates
Nick Cho
Favorite
Coble, Kelly
Boehringer Ingelheim
(
T1230-02-07
)
A Validated Immunocapture LC-MS/MS Hybrid Assay for the Quantitation of a Novel Multi-Domain Therapeutic Protein in Human Plasma with Clinical Sample Analysis
Kelly Coble
Favorite
Coleman, Holly
University of Colorado Boulder
(
W1330-01-01
)
Stabilization of Viruses for Vaccines and Gene Therapy by Spray Drying and Lyophilization
Holly Coleman
Favorite
Contrepois, Kévin
AstraZeneca
(
W1230-02-09
)
LC-MS FFPE Tissue Analysis Across Multiple Murine Tissues Supports Mouse Relevance for On-Target/Off-Tumor Toxicity Assessment for Anti-STEAP2 CAR-T Therapeutic Development
Kévin Contrepois
Favorite
Cookson, Colt
Veloxity Labs
(
W1430-02-06
)
Application of a Novel Affinity Purified Chicken IgY in an Immunoaffinity LC-MS/MS Assay for Rapid Quantitation of Monoclonal Antibody Therapeutics and ADCs in Nonclinical Species
Colt Cookson
Favorite
Cornish, Georgina
AstraZeneca
(
T1130-02-06
)
Biodistribution Analysis of GPC-3 CAR-T Cells in NSG Mice by a Universal ddPCR Assay to Support an IND-Enabling Toxicity Study
Georgina Cornish
Favorite
(
W1230-02-09
)
LC-MS FFPE Tissue Analysis Across Multiple Murine Tissues Supports Mouse Relevance for On-Target/Off-Tumor Toxicity Assessment for Anti-STEAP2 CAR-T Therapeutic Development
Georgina Cornish
Favorite
Crul, Mirjam
Amsterdam University Medical Center
(
T1030-01-03
)
Stability of Therapeutic Monoclonal Antibodies during Infusion with Elastomeric Pumps Intended for Home-Based Therapy
Mirjam Crul
Favorite
Cueto, Maria
Merck & Co., Inc.
(
T1230-01-01
)
Parallel-Competitive Absorption Metabolism Model for Calculation of Subcutaneous Bioavailability of Monoclonal Antibodies
Maria Cueto
Favorite
